Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla PTC Therapeutics, Inc.
| Okres |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1,758.01 |
878.21 |
1,131.03 |
1,183.95 |
1,414.10 |
| Przychód Δ r/r |
0.00% |
-50.05% |
28.79% |
4.68% |
19.44% |
| Przychód (min) |
1,633.54 |
723.01 |
1,087.68 |
787.95 |
941.11 |
| Przychód (max) |
1,882.48 |
1,280.92 |
1,174.37 |
1,459.99 |
1,743.80 |
| EBITDA (średnia) |
-880.09 |
-439.65 |
-566.22 |
-592.71 |
-707.93 |
| EBIT (średnia) |
-1,159.06 |
-579.01 |
-745.69 |
-780.58 |
-932.32 |
| EBIT % |
-65.93% |
-65.93% |
-65.93% |
-65.93% |
-65.93% |
| Zysk netto (średni) |
593.76 |
-202.43 |
-0.01 |
2.28 |
152.77 |
| Zysk netto % |
33.77% |
-23.05% |
-0.00% |
0.19% |
10.80% |
| EPS (średnia) |
7.73 |
-2.36 |
0.20 |
0.03 |
1.99 |
| Liczba analityków (Przychody) |
8 |
15 |
10 |
4 |
5 |
| Liczba analityków (EPS) |
5 |
9 |
9 |
4 |
3 |
| symbol |
PTCT |
PTCT |
PTCT |
PTCT |
PTCT |